{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:34:13Z","timestamp":1783521253611,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007924","name":"University of Louisville","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32ES11564"],"award-info":[{"award-number":["T32ES11564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25CA134283"],"award-info":[{"award-number":["R25CA134283"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bbrc.2020.10.021","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T01:28:52Z","timestamp":1603243732000},"page":"1366-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids"],"prefix":"10.1016","volume":"533","author":[{"given":"Sarah H.","family":"Shrader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Guang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell B.","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2020.10.021_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2020.10.021_bib2","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bbrc.2020.10.021_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2020.10.021_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson\u2019s disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.bbrc.2020.10.021_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-017-4766-7","article-title":"Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology","volume":"235","author":"Hudson","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.bbrc.2020.10.021_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbrc.2020.10.021_bib7","series-title":"Biogenic Amine Neurotransmitters in C. elegans","first-page":"1","author":"Chase","year":"2007"},{"issue":"5","key":"10.1016\/j.bbrc.2020.10.021_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2031","article-title":"Finding function in novel targets: C. elegans as a model organism","volume":"5","author":"Kaletta","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5396","key":"10.1016\/j.bbrc.2020.10.021_bib9","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1126\/science.282.5396.2012","article-title":"Genome sequence of the nematode C. elegans: a platform for investigating biology","volume":"282","author":"Consortium","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbrc.2020.10.021_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/hmg\/9.6.869","article-title":"A\u00a0role for Caenorhabditis elegans in understanding the function and interactions of human disease genes","volume":"9","author":"Culetto","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.bbrc.2020.10.021_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1010306731764","article-title":"The use of functional genomics in C. elegans for studying human development and disease","volume":"24","author":"Kuwabara","year":"2001","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"1165","key":"10.1016\/j.bbrc.2020.10.021_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rstb.1986.0056","article-title":"The structure of the nervous system of the nematode Caenorhabditis elegans","volume":"314","author":"White","year":"1986","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2020.10.021_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2004.05.010","article-title":"Biogenic amine receptors in parasitic nematodes: what can be learned from Caenorhabditis elegans?","volume":"137","author":"Komuniecki","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"issue":"51","key":"10.1016\/j.bbrc.2020.10.021_bib14","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1523\/JNEUROSCI.2992-07.2007","article-title":"Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1","volume":"27","author":"McDonald","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"8","key":"10.1016\/j.bbrc.2020.10.021_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1534\/g3.112.003533","article-title":"Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis","volume":"2","author":"Hardaway","year":"2012","journal-title":"G3 (Bethesda)"},{"issue":"37","key":"10.1016\/j.bbrc.2020.10.021_bib16","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1073\/pnas.0802214105","article-title":"Dopamine transporter\/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission","volume":"105","author":"Carvelli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.10.021_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuint.2016.01.008","article-title":"Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in\u00a0vivo","volume":"98","author":"Bermingham","year":"2016","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.bbrc.2020.10.021_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216417","article-title":"Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1","volume":"14","author":"Robinson","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.10.021_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuint.2018.05.013","article-title":"Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone","volume":"123","author":"Refai","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2020.10.021_bib20","series-title":"Maintenance of C. elegans","first-page":"1","author":"Stiernagle","year":"2006"},{"key":"10.1016\/j.bbrc.2020.10.021_bib21","article-title":"Swimming induced paralysis to assess dopamine signaling in Caenorhabditis elegans","volume":"146","author":"Kudumala","year":"2019","journal-title":"JoVE"},{"key":"10.1016\/j.bbrc.2020.10.021_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-61779-867-2_3","article-title":"Caenorhabditis elegans as a model in developmental toxicology","volume":"889","author":"Boyd","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.bbrc.2020.10.021_bib23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nn1316","article-title":"Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans","volume":"7","author":"Chase","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"6526","key":"10.1016\/j.bbrc.2020.10.021_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/375073a0","article-title":"A\u00a0calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans","volume":"375","author":"Schafer","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.10.021_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2020.10.021_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2018.08.016","article-title":"Cannabinoid pharmacology\/therapeutics in chronic degenerative disorders affecting the central nervous system","volume":"157","author":"Aymerich","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2020.10.021_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"Pt B","key":"10.1016\/j.bbrc.2020.10.021_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.bbrc.2020.10.021_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.bbrc.2020.10.021_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","article-title":"Targeting the endocannabinoid system in psychiatric illness","volume":"36","author":"Katzman","year":"2016","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2020.10.021_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.biopsych.2015.11.018","article-title":"Therapeutic potential of cannabinoids in psychosis","volume":"79","author":"Leweke","year":"2016","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.bbrc.2020.10.021_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.bbrc.2020.10.021_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2016.10.011","article-title":"New concepts in dopamine D2 receptor biased signaling and implications for schizophrenia therapy","volume":"81","author":"Urs","year":"2017","journal-title":"Biol. Psychiatr."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20319306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20319306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:47:49Z","timestamp":1777391269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20319306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0006291X20319306"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.021","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}